Research programme: proto-oncogene-protein-c-bcl-2-inhibitors - AbbVie
Alternative Names: A-371191; A-385358; ABT 737Latest Information Update: 22 Apr 2014
Price :
$50 *
At a glance
- Originator Idun Pharmaceuticals
- Developer Abbott Laboratories
- Class Small molecules
- Mechanism of Action Apoptosis stimulants; Proto-oncogene protein c-bcl-2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer